Healthequity Stock Number Of Shares Shorted
HQY Stock | USD 78.55 1.20 1.50% |
HealthEquity fundamentals help investors to digest information that contributes to HealthEquity's financial success or failures. It also enables traders to predict the movement of HealthEquity Stock. The fundamental analysis module provides a way to measure HealthEquity's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to HealthEquity stock.
HealthEquity | Number Of Shares Shorted |
HealthEquity Company Number Of Shares Shorted Analysis
HealthEquity's Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
Current HealthEquity Number Of Shares Shorted | 3.02 M |
Most of HealthEquity's fundamental indicators, such as Number Of Shares Shorted, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, HealthEquity is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
HealthEquity Number Of Shares Shorted Driver Correlations
Understanding the fundamental principles of building solid financial models for HealthEquity is extremely important. It helps to project a fair market value of HealthEquity Stock properly, considering its historical fundamentals such as Number Of Shares Shorted. Since HealthEquity's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of HealthEquity's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of HealthEquity's interrelated accounts and indicators.
Click cells to compare fundamentals
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
Competition |
Based on the recorded statements, HealthEquity has 3.02 M of outstending shares currently sold short by investors. This is 5.74% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The number of shares shorted for all United States stocks is 35.91% higher than that of the company.
HealthEquity Number Of Shares Shorted Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses HealthEquity's direct or indirect competition against its Number Of Shares Shorted to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of HealthEquity could also be used in its relative valuation, which is a method of valuing HealthEquity by comparing valuation metrics of similar companies.HealthEquity is currently under evaluation in number of shares shorted category among related companies.
HealthEquity Fundamentals
Return On Equity | 0.0284 | ||||
Return On Asset | 0.0256 | ||||
Profit Margin | 0.06 % | ||||
Operating Margin | 0.16 % | ||||
Current Valuation | 7.4 B | ||||
Shares Outstanding | 86.16 M | ||||
Shares Owned By Insiders | 2.20 % | ||||
Shares Owned By Institutions | 97.80 % | ||||
Number Of Shares Shorted | 3.02 M | ||||
Price To Earning | 525.29 X | ||||
Price To Book | 3.38 X | ||||
Price To Sales | 6.88 X | ||||
Revenue | 999.59 M | ||||
Gross Profit | 490.09 M | ||||
EBITDA | 281.21 M | ||||
Net Income | 55.71 M | ||||
Cash And Equivalents | 176.89 M | ||||
Cash Per Share | 2.09 X | ||||
Total Debt | 933.14 M | ||||
Debt To Equity | 0.54 % | ||||
Current Ratio | 2.46 X | ||||
Book Value Per Share | 23.63 X | ||||
Cash Flow From Operations | 242.83 M | ||||
Short Ratio | 4.57 X | ||||
Earnings Per Share | 0.64 X | ||||
Price To Earnings To Growth | 2.29 X | ||||
Target Price | 99.23 | ||||
Number Of Employees | 3.13 K | ||||
Beta | 0.55 | ||||
Market Capitalization | 6.8 B | ||||
Total Asset | 3.24 B | ||||
Retained Earnings | 205.63 M | ||||
Working Capital | 440.35 M | ||||
Current Asset | 143.05 M | ||||
Current Liabilities | 12.11 M | ||||
Net Asset | 3.24 B |
About HealthEquity Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze HealthEquity's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of HealthEquity using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of HealthEquity based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
HealthEquity Investors Sentiment
The influence of HealthEquity's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in HealthEquity. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to HealthEquity's public news can be used to forecast risks associated with an investment in HealthEquity. The trend in average sentiment can be used to explain how an investor holding HealthEquity can time the market purely based on public headlines and social activities around HealthEquity. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
HealthEquity's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for HealthEquity's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average HealthEquity's news discussions. The higher the estimated score, the more favorable is the investor's outlook on HealthEquity.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards HealthEquity in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, HealthEquity's short interest history, or implied volatility extrapolated from HealthEquity options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out HealthEquity Piotroski F Score and HealthEquity Altman Z Score analysis. For more information on how to buy HealthEquity Stock please use our How to Invest in HealthEquity guide.You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for HealthEquity Stock analysis
When running HealthEquity's price analysis, check to measure HealthEquity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HealthEquity is operating at the current time. Most of HealthEquity's value examination focuses on studying past and present price action to predict the probability of HealthEquity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HealthEquity's price. Additionally, you may evaluate how the addition of HealthEquity to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Share Portfolio Track or share privately all of your investments from the convenience of any device |
Is HealthEquity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of HealthEquity. If investors know HealthEquity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about HealthEquity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.96) | Earnings Share 0.64 | Revenue Per Share 11.682 | Quarterly Revenue Growth 0.122 | Return On Assets 0.0256 |
The market value of HealthEquity is measured differently than its book value, which is the value of HealthEquity that is recorded on the company's balance sheet. Investors also form their own opinion of HealthEquity's value that differs from its market value or its book value, called intrinsic value, which is HealthEquity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because HealthEquity's market value can be influenced by many factors that don't directly affect HealthEquity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between HealthEquity's value and its price as these two are different measures arrived at by different means. Investors typically determine if HealthEquity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, HealthEquity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.